Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Neuropilin 1 ELISA Kit (AC3858)
Cat.#: ASET-2447
Specifications
Description Human Neuropilin 1 ELISA Kit allows for the in vitro quantitative determination of human Neuropilin 1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1216 Mouse VEGFC ELISA Kit (AC2627) Quantitative inquiry ASET-1233 Human TAS2R38 ELISA Kit (AC2644) Quantitative inquiry ASET-2093 Human HEXA ELISA Kit (AC3504) Quantitative inquiry ASET-2226 Human CNTF ELISA Kit (AC3637) Quantitative inquiry ASET-1689 Human GABA A Receptor alpha 1 ELISA Kit (AC3100) Quantitative inquiry ASET-1060 Mouse Homer1 ELISA Kit (AC2471) Quantitative inquiry ASET-2321 Mouse Dehydroepiandrosterone ELISA Kit (AC3732) Quantitative inquiry ASET-1701 Rat CACNA1A ELISA Kit (AC3112) Quantitative inquiry ASET-2087 Human Wnt6 ELISA Kit (AC3498) Quantitative inquiry ASET-2513 Human AMPK alpha 1 ELISA Kit (AC3924) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket